|
volume 16
number 3 page 243 Linheng Li1,6, Ian D. Krantz2, Yu Deng3,6,
Anna Genin2, Amy B. Banta1,6 , Colin C. Collins4,
Ming Qi5, Barbara J. Trask6, Wen Lin Kuo7,
Joanne Cochran4, Teresa Costa8, Mary Ella M. Pierpont9,
Elizabeth B. Rand10, David A. Piccoli10, Leroy Hood1,6
& Nancy B. Spinner2 Alagille
syndrome is an autosomal dominant disorder characterized by abnormal development
of liver, heart, skeleton, eye, face and, less frequently, kidney. Analyses
of many patients with cytogenetic deletions or rearrangements have mapped the
gene to chromosome 20p12, although deletions are found in a relatively small
proportion of patients (< 7%). We have mapped the human Jagged1 gene
(JAG1), encoding a ligand for the developmentally important Notch
transmembrane receptor, to the Alagille syndrome critical region within
20p12. The Notch intercellular signalling pathway has been shown to mediate
cell fate decisions during development in invertebrates and vertebrates. We
demonstrate four distinct coding mutations in JAG1 from four Alagille
syndrome families, providing evidence that it is the causal gene for Alagille
syndrome. All four mutations lie within conserved regions of the gene and
cause translational frameshifts, resulting in gross alterations of the
protein product. Patients with cytogenetically detectable deletions including
JAG1 have Alagille syndrome, supporting the hypothesis that
haploinsufficiency for this gene is one of the mechanisms causing the
Alagille syndrome phenotype.
1Stowers Institute for Medical Research, 6Department
of Molecular Biotechnology, University of Washington, Seattle, Washington
98195, USA. 2Division of Human Genetics, 10Division of
Gastroenterology and Nutrition, The Children's Hospital of Philadelphia,
University of Pennsylvania School of Medicine, 324 S 34th Street,
Philadelphia, Pennsylvania 19104, USA. 3Institute of Genetics,
Fudan University, Shanghai, 200433, China. 4Resource for Molecular
Cytogenetics, Life Sciences Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720, USA. 5Division of Medical Genetics,
Departments of Medicine & Pathology, University of Washington, Seattle,
WA 98195, USA. 7University of California San Francisco Cancer
Center, Cancer Genetics Program, San Francisco California 941413, USA. 8The
Hospital for Sick Children, Department of Genetics, 555 University Avenue
Toronto, Ontario M5G 1X8, Canada. 9Department of Pediatrics and
Institute of Human Genetics, University of Minnesota, Minneapolis MN, USA.
Correspondence should be addressed to N.B.S. (spinner@mail.med.upenn.edu) or
L.H. (lee@nirvana.MBT.Washington.edu) |